Current progress in cancer immunotherapy based on natural killer cells

Current progress in cancer immunotherapy based on natural killer cells


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: یاسین باقری , علیرضا براتی , علی عاقبتی ملکی , لیلی عاقبتی , مهدی یوسفی

کلمات کلیدی: activating receptors; cancer; chimeric antigen receptors; clinical application; inhibitory receptors; natural Killer Cells

نشریه: 6324 , 1 , 45 , 2020

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله لیلی عاقبتی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات ایمونولوژی
کد مقاله 75492
عنوان فارسی مقاله Current progress in cancer immunotherapy based on natural killer cells
عنوان لاتین مقاله Current progress in cancer immunotherapy based on natural killer cells
ناشر 5
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Review Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

One of the most common diseases in the present era is cancer. The common treatment methods used to control cancer include surgery, chemotherapy, and radiotherapy. Despite progress in the treatment of cancers, there still is no definite therapeutic approach. Among the currently proposed strategies, immunotherapy is a new approach that can provide better outcomes compared with existing therapies. Employing natural killer (NK) cells is one of the means of immunotherapy. As innate lymphocytes, NK cells are capable of rapidly responding to cancer cells without being sensitized or restricted to the cognate antigen in advance, as compared to T cells that are tumor antigen-specific. Latest insights into the biology of NK cells have clarified the underlying molecular mechanisms of NK cell maturation and differentiation, as well as controlling their effector functions through the investigation of the ligands and receptors engaged in recognizing cancer cells by NK cells. Elucidating the fact that NK cells recognize cancer cells could similarly show the mechanism through which cancer cells possibly avoid NK cell-dependent immune surveillance. Additionally, the expectations for novel immunotherapies by targeting NK cells have increased through the latest clinical outcomes of T–cell-targeted cancer immunotherapy. For this emerging method, researchers are still attempting to develop protocols for conferring the best proliferation and expansion medium, activation pathways, utilization dosage, transferring methods, as well as reducing possible side effects in cancer therapy. This study reviews the NK cells, their proliferation and expansion methods, and their recent applications in cancer immunotherapy.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
یاسین باقریاول
علیرضا براتیدوم
علی عاقبتی ملکیسوم
لیلی عاقبتیچهارم
مهدی یوسفیپنجم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Current progress in cancer immunotherapy based on natural.pdf1400/02/121684676دانلود